Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methylprednisolone sodium succinate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium su 125mg/2mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium su 40mg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 40mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 125mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 1g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 500mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 2g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium su 125mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Methylprednisolone sodium succinate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |